Bile Is a Hormone, Not Soap | The Angry Gut, Chapter 23

Cholecystectomy complications · Bile acid diarrhea

Cholecystectomy Complications: The Cohort Nobody Re-Screens

Bile acid diarrhea after gallbladder surgery is testable and treatable, yet 2.1% of patients are ever investigated for it. The cohort is easy to define and almost never measured.

Cholecystectomy complications are counted at thirty days and then stop being counted. The one that surfaces months later is bile acid diarrhea, which has a measured mechanism, an available test and an effective treatment, and it is investigated in a small fraction of patients. The physiology is set out on video in Bile Is a Hormone, Not Soap, chapter 23 of The Angry Gut (Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes). The operational question for a practice is narrower: which post-surgical patients deserve a second look, what the ejection fraction can and cannot decide, and what is worth measuring in the cohort that arrives after the gallbladder is gone.

The cholecystectomy complication that leaves the denominator

A multicenter audit found that of 9,439 patients who underwent the operation, 202, or 2.1%, were ever investigated for postoperative diarrhea. Among those investigated, 62.8% met criteria for bile acid diarrhea, and the median interval from surgery to the scan was 672 days. Read the direction, not the rate: only patients a clinician already suspected were referred, there was no comparison group who kept their gallbladders, and the positive proportion therefore describes the quality of the suspicion.

Prospective counting gives the cleaner estimate. Questionnaires before elective laparoscopic cholecystectomy and again at twelve months, against people coming through a health check, found new functional diarrhea in 6.6% against 0.2%, new dyspepsia in 14.8% against 6.9%, and new chronic abdominal pain in 11.9% against 4.4%. Most pre-existing symptoms improved; chronic diarrhea was the exception. The detail worth keeping is that somatization predicted the new dyspepsia and the new pain but not the new diarrhea, which is the finding that should slow down a functional label.

Why does diarrhea follow gallbladder removal?

The tidy story, that removing the tissue richest in FGF19 causes the diarrhea, was tested head-on and failed: gallbladder hormone content showed no correlation with bowel habit or stool consistency. What survives is delivery timing. After surgery bile acid synthesis rises at least two-fold and the diurnal peak of the hormone flattens, yet serum bile acids, cholesterol and triglycerides did not move in that work, which is exactly why a routine panel gives no hint of it. Bile arriving continuously into a bowel built for a postprandial bolus delivers more to the colon, where bile acids drive secretion.

I ordered ejection fractions for years and treated the cutoff as physiology rather than protocol, which was my mistake to make and worth stating before correcting anyone else’s.

Does the ejection fraction predict relief after gallbladder surgery?

Across 60 healthy volunteers at four centers, the lower limit of normal for the stimulated ejection fraction came out at 38%, and reproducibility depended entirely on the infusion: a coefficient of variation of 19% with the 60-minute infusion, and 52% with the short infusion in common use. In 93 consecutive patients with documented dyskinesia, the stimulated fraction was statistically indistinguishable between those who improved after surgery and those who did not. What predicted relief was the symptom pattern, with classic biliary pain 22 times more likely to be relieved. The operation is the right answer for a real biliary indication; the failure mode is the atypical patient selected on a number that cannot separate the two.

The terrain that arrives with the patient

In a population cohort of 4,307 people, metabolic syndrome ran 67.2% among those who had lost a gallbladder against 51.9% among those who had not, and moderate-to-severe fatty liver 42.7% against 34.2%, with imaging a median of ten years after surgery. Adjustment for metabolic factors removed both associations. That result is usually read as exoneration of the operation; the more useful reading for a practice is that this cohort was metabolically sick before the surgeon met them. Gallstones grow in bile made under hyperinsulinemia and stored in a reservoir rarely asked to empty, so the stone is a marker of the terrain and the surgery leaves the terrain in place. A cohort can adjust that away. A clinic cannot, because it walks in with the patient, and metaflammation in the first brain does not resolve because an organ was removed.

What is not a Measura test, and what is

Measura [Cardiometabolic and Autonomic Health Analysis] does not perform bile acid retention testing, gallbladder ultrasound, cholescintigraphy or breath testing, and it does not diagnose. Retention scanning is not licensed in the United States, which in practice leaves a supervised therapeutic trial with a defined endpoint and stop date as the usual route, decided by the treating clinician or gastroenterologist. What the protocol contributes is the metabolic and functional measurement this cohort almost never receives:

Laboratory panels characterize glycemic and lipid status and liver markers, which is the terrain that produced the stone and predicts the next decade.
Bioimpedance body composition separates lean from fat mass in patients who have been avoiding fat and losing muscle, which redirects counseling toward protein and loading.
Indirect calorimetry replaces a predicted resting expenditure with a measured one before any dietary target is set.
Where postprandial symptoms coexist with dizziness or presyncope, autonomic nervous system testing documents the regulatory response instead of leaving it described.

Standing orders and documentation

This cohort is easy to define, which makes it easy to protocolize. A standing order can attach a bowel-habit review and cardiometabolic measurement to any patient with a prior cholecystectomy and new or persistent loose stools, so the second look does not depend on who is in the room. The metabolic findings sit naturally in the annual wellness visit and support the measures set out in HEDIS and value-based care, while discrete results in the chart, rather than a scanned summary, are what make repeat measurement usable; see getting results into the record. Selection thresholds for the wider protocol are in the selection criteria.

The full evidence file, including the null results that constrain the mechanism, is in the book companion for The Angry Gut. The patient explanation is what bile actually does.

Frequently asked questions

Which post-cholecystectomy patients warrant investigation for bile acid diarrhea?

Those with loose or urgent stools that began after the operation and persist, particularly when fatty meals trigger them and structural workup is unremarkable. Prospective data put new functional diarrhea at 6.6% against 0.2% in controls at twelve months, and somatization did not predict it, so a functional label without testing is premature. Read the clinical rationale.

Does a low ejection fraction justify cholecystectomy in an atypical patient?

The evidence does not support deciding on that number alone. Stimulated fractions were indistinguishable between surgical responders and non-responders, while classic biliary pain was 22 times more likely to be relieved. Reproducibility also depends on infusion method, with a coefficient of variation of 19% or 52% depending on protocol. See guidance on interpreting the report.

Can Measura testing replace bile acid or gallbladder testing?

No. Retention scanning, cholescintigraphy, ultrasound and breath testing are separate investigations arranged through gastroenterology or radiology. The protocol measures the cardiometabolic, autonomic and body-composition picture, which is the part of this cohort’s risk that routinely goes undocumented, and results return to the ordering clinician. See more physician questions.

Is the metabolic association with cholecystectomy causal?

Probably not as a direct effect. In 4,307 people, metabolic syndrome ran 67.2% against 51.9% and fatty liver 42.7% against 34.2%, but adjustment for metabolic factors removed both. The practical inference is selection rather than causation: patients who form stones carry the metabolic terrain that produced them, which makes them a screening population. Read about specialty applications.

How does this fit an existing primary care workflow?

As a trigger attached to an existing cohort rather than a new clinic. Prior cholecystectomy plus persistent loose stools prompts a bowel-habit review, referral for the relevant gastroenterology testing, and cardiometabolic measurement in parallel. Staffing and supervision requirements for in-office testing are documented separately. Review staffing and workflow.

What are the long-term side effects of cholecystectomy?

In a prospective study that surveyed patients before elective laparoscopic cholecystectomy and again at twelve months, new functional diarrhea appeared in 6.6% against 0.2% of health-check controls, new dyspepsia in 14.8% against 6.9%, and new chronic abdominal pain in 11.9% against 4.4%. Most symptoms present before surgery improved. Chronic diarrhea was the exception, and it is the one worth testing.

Is it normal to have stomach issues a year after gallbladder removal?

Common is not the same as normal, and the late complication worth testing for is bile acid diarrhea. In one multicenter audit the median interval from surgery to the diagnostic scan was 672 days, and 62.8% of the patients investigated met criteria. Loose or urgent stools that began after the operation and persist, especially after fatty meals, call for a bowel-habit review rather than a functional label.

Re-screen the post-surgical cohort

Learn how the Measura protocol adds cardiometabolic, body composition and autonomic measurement to patients already carrying a post-cholecystectomy history.

Send a message

4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

References

Farrugia, A., Attard, J. A., Hanmer, S., Bullock, S., McKay, S., Al-Azzawi, M., Ali, R., Bond-Smith, G., Colleypriest, B., Dyer, S., Masterman, B., Okocha, M., Osborne, A., Patel, R., Sallam, M., Selveraj, E., Shalaby, S., Sun, W., Todd, F., … Arasaradnam, R. P. (2021). Rates of bile acid diarrhoea after cholecystectomy: A multicentre audit. World Journal of Surgery, 45(8), 2447-2453. https://doi.org/10.1007/s00268-021-06147-8
Chang, J. Y., Jung, H.-K., Moon, C. M., Kim, S.-E., Shim, K.-N., Jung, S.-A., & Min, S. K. (2023). Development of functional gastrointestinal disorder symptoms following laparoscopic cholecystectomy: A prospective cohort study. Frontiers in Medicine, 10, 1248465. https://doi.org/10.3389/fmed.2023.1248465
Farrugia, A., Williams, N., Khan, S., & Arasaradnam, R. P. (2024). Bile acid diarrhoea and metabolic changes after cholecystectomy: A prospective case-control study. BMC Gastroenterology, 24(1), 282. https://doi.org/10.1186/s12876-024-03368-8
Barrera, F., Azócar, L., Molina, H., Schalper, K. A., Ocares, M., Liberona, J., Villarroel, L., Pimentel, F., Pérez-Ayuso, R. M., Nervi, F., Groen, A. K., & Miquel, J. F. (2015). Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19. Annals of Hepatology, 14(5), 710-721. https://pubmed.ncbi.nlm.nih.gov/26256900/
Ziessman, H. A., Tulchinsky, M., Lavely, W. C., Gaughan, J. P., Allen, T. W., Maru, A., Parkman, H. P., & Maurer, A. H. (2010). Sincalide-stimulated cholescintigraphy: A multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values. Journal of Nuclear Medicine, 51(2), 277-281. https://doi.org/10.2967/jnumed.109.069393
Carr, J. A., Walls, J., Bryan, L. J., & Snider, D. L. (2009). The treatment of gallbladder dyskinesia based upon symptoms: Results of a 2-year, prospective, nonrandomized, concurrent cohort study. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, 19(3), 222-226. https://doi.org/10.1097/SLE.0b013e3181a74690
Latenstein, C. S. S., Alferink, L. J. M., Darwish Murad, S., Drenth, J. P. H., van Laarhoven, C. J. H. M., & de Reuver, P. R. (2020). The association between cholecystectomy, metabolic syndrome, and nonalcoholic fatty liver disease: A population-based study. Clinical and Translational Gastroenterology, 11(4), e00170. https://doi.org/10.14309/ctg.0000000000000170
Wedlake, L., A’Hern, R., Russell, D., Thomas, K., Walters, J. R. F., & Andreyev, H. J. N. (2009). Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 30(7), 707-717. https://doi.org/10.1111/j.1365-2036.2009.04081.x